Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes

Diabetes Care

Volumn 24, Issue 2, 2001, Pages 362-365

  Katsuki, Akira ^a   Sumida, Yasuhiro ^a   Gabazza, Esteban C ^a   Murashima, Shuichi ^a   Furuta, Masahiko ^a   Araki Sasaki, Rika ^a   Hori, Yasuko ^a   Yano, Yutaka ^a   Adachi, Yukihiko ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIET; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; JAPAN; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING;

EID: 0035142725     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.2.362     Document Type: Article

References (27)

1. The glucose clamp technique: A method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin
2. Homeostasis model assessment: Insulin resistance and β-cell function from fasting glucose and insulin concentrations in man
3. Correct homeostasis model assessment (HOMA) evaluation uses the computer program
4. Continuous infusion of glucose with model assessment: Measurement of insulin resistance and beta-cell function in men
5. Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state
6. How good a marker is insulin level for insulin resistance?
7. Acute and chronic regulation of serum sex hormone-binding globulin levels by plasma insulin concentrations in male noninsulin-dependent diabetes mellitus patients
8. How to measure insulin sensitivity
9. Evaluation Of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies
10. Glucose torelance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading
11. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas
12. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity
13. Homeostasis model assessment as a clinical index of insulin resistance: Comparison with the minimal model analysis
14. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
15. Serum levels of tumor necrosis factor-α (TNF-α) are increased in obese patients with noninsulin-dependent diabetes mellitus
16. Reversible peripheral insulin resistance in non-obese patients with noninsulin-dependent diabetes mellitus
17. Pioglitazone enhances splanchnic glucose uptake as well as peripheral glucose uptake in noninsulin-dependent diabetes mellitus: AD-4833 Clamp-OGL Study Group
18. Quantitative determination of hepatic glucose uptake using an innovative approach: Effect of strict glycemic regulation and exercise in diabetic subjects
19. A novel technique for the determination of body fat by computed tomography
20. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients: Troglitazone Study Group
21. Efficacy of troglitazone measured by insulin resistance index
22. Troglitazone reduces plasma leptin concentration but increases hunger in NIDDM patients
23. Effect of troglitazone on body fat distribution in type 2 diabetic patients
24. Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity
25. Pathophysiology and molecular mechanism of visceral fat syndrome: The Japanese experience
26. Pathogenesis of type 2 diabetes: Implications for metformin
27. Causal linkage between insulin suppression of lipolysis and supression of liver glucose output in dogs